7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine

C23H29N7 — CID 131991156

IUPAC7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
SMILESC/C(=C\NCC1CN(C)C1)c1cnc2ccc(Nc3cc(C(C)C)cnn3)nc2c1
InChIInChI=1S/C23H29N7/c1-15(2)18-8-23(29-26-12-18)28-22-6-5-20-21(27-22)7-19(11-25-20)16(3)9-24-10-17-13-30(4)14-17/h5-9,11-12,15,17,24H,10,13-14H2,1-4H3,(H,27,28,29)/b16-9+
InChIKeyCWJMWEKIVVYLBN-CXUHLZMHSA-N
MW403.53 g/mol
LogP3.80
Rot. Bonds7

About 7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine

7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine (PubChem CID 131991156) has the molecular formula C23H29N7 and a molecular weight of 403.53 g/mol. Its IUPAC name is 7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine.

Molecular Properties

Compound Name7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
PubChem CID131991156
Molecular FormulaC23H29N7
Molecular Weight403.53 g/mol
Exact Mass403.25
IUPAC Name7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine
SMILESC/C(=C\NCC1CN(C)C1)c1cnc2ccc(Nc3cc(C(C)C)cnn3)nc2c1
InChIInChI=1S/C23H29N7/c1-15(2)18-8-23(29-26-12-18)28-22-6-5-20-21(27-22)7-19(11-25-20)16(3)9-24-10-17-13-30(4)14-17/h5-9,11-12,15,17,24H,10,13-14H2,1-4H3,(H,27,28,29)/b16-9+
InChIKeyCWJMWEKIVVYLBN-CXUHLZMHSA-N
XLogP3.80
TPSA78.86 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500403.53
LogP ≤ 53.80
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze 7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine?
The IUPAC name of 7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine (CID 131991156) is 7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine.
What is the SMILES notation for 7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine?
The canonical SMILES for 7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine is C/C(=C\NCC1CN(C)C1)c1cnc2ccc(Nc3cc(C(C)C)cnn3)nc2c1.
What is the InChIKey of 7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine?
The InChIKey is CWJMWEKIVVYLBN-CXUHLZMHSA-N. The full InChI is InChI=1S/C23H29N7/c1-15(2)18-8-23(29-26-12-18)28-22-6-5-20-21(27-22)7-19(11-25-20)16(3)9-24-10-17-13-30(4)14-17/h5-9,11-12,15,17,24H,10,13-14H2,1-4H3,(H,27,28,29)/b16-9+.
What are the key properties of 7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine?
7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine has a molecular weight of 403.53 g/mol, XLogP of 3.80, 7 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 7-[(E)-1-[(1-methylazetidin-3-yl)methylamino]prop-1-en-2-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine is sourced from PubChem (CID 131991156), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).